APTO Archived Articles
Aptose Biosciences Inc. (APTO): Unlocking the Potential of Targeted Therapies in Hematologic Malignancies
Published on November 30, 2024
Aptose Biosciences Inc. (NASDAQ:APTO): Developing a Promising Frontline Therapy for Newly Diagnosed AML Patients
Published on September 24, 2024